Cellular and Molecular Mediators of Neuroinflammation in Alzheimer Disease

키워드

참고문헌 (95)

1. Alzheimer’s Association, "2012 Alzheimer’s disease facts and figures", Alzheimers Dement, 8, pp.131~168 (2012)
2. Brookmeyer R, "Forecasting the global burden of Alzheimer’s disease", Alzheimers Dement, 3, pp.186~191 (2007)
3. Jin M, "Soluble amyloid beta-protein dimers isolated from Alzheimer cortex directly induce Tau hyperphosphorylation and neuritic degeneration", Proc Natl Acad Sci U S A, 108, pp.5819~5824 (2011)
4. Schoonenboom NS, "Amyloid beta(1-42)and phosphorylated tau in CSF as markers for early-onset Alzheimer disease", Neurology, 62, pp.1580~1584 (2004)
5. Sobow T, "Amyloid-beta and tau proteins as biochemical markers of Alzheimer’s disease", Acta Neurobiol Exp(Wars), 64, pp.53~70 (2004)
6. Gong CX, "Hyperphosphorylation of microtubule-associated protein tau : a promising therapeutic target for Alzheimer disease", Curr Med Chem, 15, pp.2321~2328 (2008)
7. Fischer P, "Risk factors for Alzheimer dementia in a community-based birth cohort at the age of 75 years", Dement Geriatr Cogn Disord, 25, pp.501~507 (2008)
8. Serrano-Pozo A, "Reactive glia not only associates with plaques but also parallels tangles in Alzheimer’s disease", Am J Pathol, 179, pp.1373~1384 (2011)
9. Bu XL, "A study on the association between infectious burden and Alzheimer’s disease", Eur J Neurol, 22, pp.1519~1525 (2015)
10. Budni J, "The anti-inflammatory role of minocycline in Alzheimer’s disease", Curr Alzheimer Res, 13, pp.1319~1329 (2016)
11. Lambert JC, "Meta-analysis of 74, 046 individuals identifies 11new susceptibility loci for Alzheimer’s disease", Nat Genet, 45, pp.1452~1458 (2013)
12. Iversen LL, "The toxicity in vitro of beta-amyloid protein", Biochem J, 311(Pt 1), pp.1~16 (1995)
13. Meraz-Rios MA, "Inflammatory process in Alzheimer’s disease", Front Integr Neurosci, 7, pp.59~ (2013)
14. Kettenmann H, "Physiology of microglia", Physiol Rev, 91, pp.461~553 (2011)
15. Kierdorf K, "Microglia in steady state", J Clin Invest, 127, pp.3201~3209 (2017)
16. Heneka MT, "Neuroinflammation in Alzheimer’s disease", Lancet Neurol, 14, pp.388~405 (2015)
17. Ji K, "Microglia actively regulate the number of functional synapses", PLoS One, 8, pp.e56293~ (2013)
18. Bamberger ME, "A cell surface receptor complex for fibrillar beta-amyloid mediates microglial activation", J Neurosci, 23, pp.2665~2674 (2003)
19. Paresce DM, "Microglial cells internalize aggregates of the Alzheimer’s disease amyloid beta-protein via a scavenger receptor", Neuron, 17, pp.553~565 (1996)
20. Stewart CR, "CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer", Nat Immunol, 11, pp.155~161 (2010)
21. Liu Y, "LPS receptor (CD14): a receptor for phagocytosis of Alzheimer’s amyloid peptide", Brain, 128(Pt 8), pp.1778~1789 (2005)
22. El Khoury JB, "CD36 mediates the innate host response to beta-amyloid", J Exp Med, 197, pp.1657~1666 (2003)
23. Sheedy FJ, "CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation", Nat Immunol, 14, pp.812~820 (2013)
24. Lee CY, "The role of microglia in amyloid clearance from the AD brain", J Neural Transm(Vienna), 117, pp.949~960 (2010)
25. Wyss-Coray T, "Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer’s mice", Proc Natl Acad Sci U S A, 99, pp.10837~10842 (2002)
26. Chakrabarty P, "Massive gliosis induced by interleukin-6 suppresses Abeta deposition in vivo : evidence against inflammation as a driving force for amyloid deposition", FASEB J, 24, pp.548~559 (2010)
27. Shaftel SS, "Sustained hippocampal IL-1 beta overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology", J Clin Invest, 117, pp.1595~1604 (2007)
28. Hickman SE, "Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer’s disease mice", J Neurosci, 28, pp.8354~8360 (2008)
29. Meda L, "Activation of microglial cells by beta-amyloid protein and interferon-gamma", Nature, 374, pp.647~650 (1995)
30. Jay TR, "TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models", J Exp Med, 212, pp.287~295 (2015)
31. Bemiller SM, "TREM2 deficiency exacerbates tau pathology through dysregulated kinase signaling in a mouse model of tauopathy", Mol Neurodegener, 12, pp.74~ (2017)
32. Savage JC, "Nuclear receptors license phagocytosis by trem2+ myeloid cells in mouse models of Alzheimer’s disease", J Neurosci, 35, pp.6532~6543 (2015)
33. Guerreiro R, "TREM2 variants in Alzheimer’s disease", N Engl J Med, 368, pp.117~127 (2013)
34. Hickman SE, "TREM2 and the neuroimmunology of Alzheimer’s disease", Biochem Pharmacol, 88, pp.495~498 (2014)
35. Jin SC, "TREM2 is associated with increased risk for Alzheimer’s disease in African Americans", Mol Neurodegener, 10, pp.19~ (2015)
36. Perry VH, "Microglia and macrophages of the central nervous system : the contribution of microglia priming and systemic inflammation to chronic neurodegeneration", Semin Immunopathol, 35, pp.601~612 (2013)
37. Boche D, "Review : activation patterns of microglia and their identification in the human brain", Neuropathol Appl Neurobiol, 39, pp.3~18 (2013)
38. Town T, "The microglial"activation"continuum : from innate to adaptive responses", J Neuroinflammation, 2, pp.24~ (2005)
39. Zare A, "Unveiling the sensory connections between the bladder and the brain that involve the periaqueductal gray matter", Maastricht University, ~ (2018)
40. Halassa MM, "Integrated brain circuits : astrocytic networks modulate neuronal activity and behavior", Annu Rev Physiol, 72, pp.335~355 (2010)
41. Sofroniew MV, "Astrocytes : biology and pathology", Acta Neuropathol, 119, pp.7~35 (2010)
42. Henneberger C, "Long-term potentiation depends on release of D-serine from astrocytes", Nature, 463, pp.232~236 (2010)
43. Olabarria M, "Concomitant astroglial atrophy and astrogliosis in a triple transgenic animal model of Alzheimer’s disease", Glia, 58, pp.831~838 (2010)
44. Olabarria M, "Age-dependent decrease in glutamine synthetase expression in the hippocampal astroglia of the triple transgenic Alzheimer’s disease mouse model : mechanism for deficient glutamatergic transmission?", Mol Neurodegener, 6, pp.55~ (2011)
45. Yeh CY, "Early astrocytic atrophy in the entorhinal cortex of a triple transgenic animal model of Alzheimer’s disease", ASN Neuro, 3, pp.271~279 (2011)
46. Carrero I, "Oligomers of beta-amyloid protein(Abeta1-42)induce the activation of cyclooxygenase-2 in astrocytes via an interaction with interleukin-1beta, tumour necrosis factor-alpha, and a nuclear factor kappa-B mechanism in the rat brain", Exp Neurol, 236, pp.215~227 (2012)
47. Kobayashi K, "Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer’s disease", Neuropathol Appl Neurobiol, 28, pp.238~251 (2002)
48. Roth AD, "Oligodendrocytes damage in Alzheimer’s disease : beta amyloid toxicity and inflammation", Biol Res, 38, pp.381~387 (2005)
49. Mitew S, "Focal demyelination in Alzheimer’s disease and transgenic mouse models", Acta Neuropathol, 119, pp.567~577 (2010)
50. Jantaratnotai N, "Amyloid beta peptide-induced corpus callosum damage and glial activation in vivo", Neuroreport, 14, pp.1429~1433 (2003)
51. Xu J, "Amyloid-beta peptides are cytotoxic to oligodendrocytes", J Neurosci, 21, pp.RC118~ (2001)
52. Lee JT, "Amyloid-beta peptide induces oligodendrocyte death by activating the neutral sphingomyelinase-ceramide pathway", J Cell Biol, 164, pp.123~131 (2004)
53. Desai MK, "An Alzheimer’s disease-relevant presenilin-1 mutation augments amyloid-beta-induced oligodendrocyte dysfunction", Glia, 59, pp.627~640 (2011)
54. Hosokawa M, "Expression of complement messenger RNAs and proteins by human oligodendroglial cells", Glia, 42, pp.417~423 (2003)
55. Forneris F, "The modular serine proteases of the complement cascade", Curr Opin Struct Biol, 22, pp.333~341 (2012)
56. Noris M, "Overview of complement activation and regulation", Semin Nephrol, 33, pp.479~492 (2013)
57. Gasque P, "The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system : analysis in multiple sclerosis and bacterial meningitis", J Immunol, 160, pp.3543~3554 (1998)
58. Gasque P, "Expression of the complement classical pathway by human glioma in culture. A model for complement expression by nerve cells", J Biol Chem, 268, pp.25068~25074 (1993)
59. Ricklin D, "Complement : a key system for immune surveillance and homeostasis", Nat Immunol, 11, pp.785~797 (2010)
60. Maier M, "Complement C3 deficiency leads to accelerated amyloid beta plaque deposition and neurodegeneration and modulation of the microglia", macrophage phenotype in amyloid precursor protein transgenic mice, 2008, pp.28, 6333~6341
61. Webster SD, "Complement component C1q modulates the phagocytosis of Abeta by microglia", Exp Neurol, 161, pp.127~138 (2000)
62. Fonseca MI, "Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer’s disease", J Neurosci, 24, pp.6457~6465 (2004)
63. Blum-Degen D, "Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer’s and de novo Parkinson’s disease patients", Neurosci Lett, 202, pp.17~20 (1995)
64. Jiang H, "Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer’s disease", Mol Neurodegener, 6, pp.69~ (2011)
65. "J Neuroimmunol", 1999, 45~52
66. Patel NS, "Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer’s disease", J Neuroinflammation, 2, pp.9~ (2005)
67. Chang R, "Tumor necrosis factor alpha Inhibition for Alzheimer’s Disease", J Cent Nerv Syst Dis, 9 (2017)
68. Combs CK, "Beta-amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis", J Neurosci, 21, pp.1179~1188 (2001)
69. Blasko I, "Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes", Neurobiol Dis, 7(6 Pt B), pp.682~689 (2000)
70. Liao YF, "Tumor necrosis factor-alpha, interleukin-1beta, and interferon-gamma stimulate gamma-secretase-mediated cleavage of amyloid precursor protein through a JNK-dependent MAPK pathway", J Biol Chem, 279, pp.49523~49532 (2004)
71. He P, "Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer’s mice", J Cell Biol, 178, pp.829~841 (2007)
72. Akiyama H, "Inflammation and Alzheimer’s disease", Neurobiol Aging, 21, pp.383~421 (2000)
73. Griffin WS, "Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease", Proc Natl Acad Sci U S A, 86, pp.7611~7615 (1989)
74. Sheng JG, "Interleukin-1promotes expression and phosphorylation of neurofilament and tau proteins in vivo", Exp Neurol, 163, pp.388~391 (2000)
75. Li Y, "Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38-MAPK pathway", J Neurosci, 23, pp.1605~1611 (2003)
76. Rothaug M, "The role of interleukin-6signaling in nervous tissue", Biochim Biophys Acta, 1863(6 Pt A), pp.1218~1227 (2016)
77. Ringheim GE, "Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor", interleukin-6 complex, 1998, pp.55, 35~44
78. Quintanilla RA, "Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5", p35 pathway, 2004, pp.295, 245~257
79. Cyster JG, "Chemokines and cell migration in secondary lymphoid organs", Science, 286, pp.2098~2102 (1999)
80. Ransohoff RM, "The chemokine system in neuroinflammation: an update", J Infect Dis, 186(Suppl 2), pp.S152~156 (2002)
81. Liu C, "Neuroinflammation in Alzheimer’s disease : chemokines produced by astrocytes and chemokine receptors", Int J Clin Exp Pathol, 7, pp.8342~8355 (2014)
82. Zuena AR, "Chemokines in Alzheimer’s disease : new insights into prokineticins, chemokine-like proteins", Front Pharmacol, 10, pp.622~ (2019)
83. Ishizuka K, "Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer’s disease", Psychiatry Clin Neurosci, 51, pp.135~138 (1997)
84. Xia MQ, "Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5and their ligands in normal and Alzheimer’s disease brains", Am J Pathol, 153, pp.31~37 (1998)
85. Westin K, "CCL2 is associated with a faster rate of cognitive decline during early stages of Alzheimer’s disease", PLoS One, 7, pp.e30525~ (2012)
86. Smits HA, "Amyloid-beta-induced chemokine production in primary human macrophages and astrocytes", J Neuroimmunol, 127, pp.160~168 (2002)
87. Fuhrmann M, "Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer’s disease", Nat Neurosci, 13, pp.411~413 (2010)
88. Lee S, "CX3CR1 deficiency alters microglial activation and reduces beta-amyloid deposition in two Alzheimer’s disease mouse models", Am J Pathol, 177, pp.2549~2562 (2010)
89. Cho SH, "CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease", J Biol Chem, 286, pp.32713~32722 (2011)
90. Hoozemans JJ, "Cyclooxygenase-1 and-2 in the different stages of Alzheimer’s disease pathology", Curr Pharm Des, 14, pp.1419~1427 (2008)
91. Smith WL, "Cyclooxygenases : structural, cellular, and molecular biology", Annu Rev Biochem, 69, pp.145~182 (2000)
92. Warner TD, "Cyclooxygenases : new forms, new inhibitors, and lessons from the clinic", FASEB J, 18, pp.790~804 (2004)
93. Xiang Z, "Cyclooxygenase-2 promotes amyloid plaque deposition in a mouse model of Alzheimer’s disease neuropathology", Gene Expr, 10, pp.271~278 (2002)
94. Xiang Z, "Cyclooxygenase(COX)-2 and cell cycle activity in a transgenic mouse model of Alzheimer’s disease neuropathology", Neurobiol Aging, 23, pp.327~334 (2002)
95. Pasinetti GM, "Cyclooxygenase and inflammation in Alzheimer’s disease : experimental approaches and clinical interventions", J Neurosci Res, 54, pp.1~6 (1998)

관련 논문AI추천